This research demonstrates the role of METTL1 in leukemia stem cells in myeloid leukemia, suggesting small-molecule inhibitors may offer a new therapeutic approach.
Key Points
The aim is to investigate METTL1's role in myeloid leukemia and assess its potential as a therapeutic target.
Used genome-wide CRISPR/Cas9 screens to analyze METTL1's role in leukemia stem cells.
Conducted transcriptomic analysis on hematopoietic cells from Mettl1 conditional knockout mice.
Screened 264,086 small-molecule inhibitors for METTL1 targeting efficacy.
Identified METTL1 as crucial for leukemia stem cell self-renewal in myeloid leukemia.